| Title: | Identifying the lungs as a susceptible site for allele-specific regulatory changes associated with type 1 diabetes risk |
| Journal: | Communications Biology |
| Published: | 14 Sep 2021 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/34521982/ |
| DOI: | https://doi.org/10.1038/s42003-021-02594-0 |
| URL: | https://www.nature.com/articles/s42003-021-02594-0.pdf |
| Citations: | 4 (3 in last 2 years) as of 8 Aug 2024 |
Publication 5184
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Type 1 diabetes (T1D) etiology is complex. We developed a machine learning approach that ranked the tissue-specific transcription regulatory effects for T1D SNPs and estimated their relative contributions to conversion to T1D by integrating case and control genotypes (Wellcome Trust Case Control Consortium and UK Biobank) with tissue-specific expression quantitative trait loci (eQTL) data. Here we show an eQTL (rs6679677) associated with changes to AP4B1-AS1 transcript levels in lung tissue makes the largest gene regulatory contribution to the risk of T1D development. Luciferase reporter assays confirmed allele-specific enhancer activity for the rs6679677 tagged locus in lung epithelial cells (i.e. A549 cells; C > A reduces expression, p = 0.005). Our results identify tissue-specific eQTLs for SNPs associated with T1D. The strongest tissue-specific eQTL effects were in the lung and may help explain associations between respiratory infections and risk of islet autoantibody seroconversion in young children.</p>
9 Authors
- Daniel Ho
- Denis M. Nyaga
- William Schierding
- Richard Saffery
- Jo K. Perry
- John A. Taylor
- Mark H. Vickers
- Andreas W. Kempa-Liehr
- Justin M. O'Sullivan
Enabling scientific discoveries that improve human health